• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEART VALVES SANTA ANA HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEART VALVES SANTA ANA HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number T505
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Bradycardia (1751); Stroke/CVA (1770); Endocarditis (1834); Hematoma (1884); Low Blood Pressure/ Hypotension (1914); Unspecified Infection (1930); Pericardial Effusion (3271); Cardiovascular Insufficiency (4445); Pulmonary Valve Insufficiency/ Regurgitation (4452)
Event Date 08/18/2021
Event Type  Injury  
Manufacturer Narrative
Citation: hribernik et al.Comparative analysis of surgical and percutaneous pulmonary valve implants over a 20-year period.Eur j c ardiothorac surg.2021 aug 18;ezab368.Doi: 10.1093/ejcts/ezab368.Earliest date of publish used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding comparison of surgical and transcatheter pulmonary valve implants over a 20-year period.All data were collected from a single center between august 1998 to april 2020.The study population included a total of 493 patients (predominantly male, mean age 26.3 years, mean weight 67.1 kg) with 365 patients in the surgical group and 128 patients in the transcatheter group.Multiple manufacturer¿s devices were implanted in the study population.Among all patients 80 were implanted with a medtronic device: in the surgical group 14 received a hancock aortic valve and 2 received a medtronic contegra conduit, and in the transcatheter group 64 received a melody bioprosthetic valve.No unique device identifier numbers were provided for these devices.Among all patients, 4 deaths (4 surgical and 0 transcatheter) occurred within 30 days and 22 deaths (16 surgical and 6 transcatheter) occurred during the follow-up period.Based on the available information medtronic product was not directly associated with the death(s).Among patients in the surgical group, adverse events included: endocarditis (median time 13 months post-implant), sternal infection/ dehiscence, mediastinal hematoma, pericardial effusion requiring pericardiocentesis, iatrogenic ventricular injury requiring pericardial patch, coronary artery injury requiring intraoperative repair, postoperative hypotension, right ventricular outflow tract (rvot ) obstruction due to rotation of pulmonary valve requiring valve explant, bradycardia requiring permanent pacemaker implant, postoperative stroke, high pressure gradients (25.4 mmhg), and severe pulmonary regurgitation.Based on the available information medtronic product may have been associated with the adverse event(s).Among patients in the transcatheter group, adverse events included: endocarditis (melody median time 27.5 months post-implant), sternal pulmonary edema, rvot conduit rupture, valve embolization, hematoma, high pressure gradients (26.9 mmhg), and moderate pulmonary regurgitation.Based on the available information medtronic product may have been associated with the adverse event(s).Based on the available information medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
HEART VALVES SANTA ANA
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
HEART VALVES SANTA ANA
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12701841
MDR Text Key278554026
Report Number2025587-2021-03164
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 10/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberT505
Device Catalogue NumberT505
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age26 YR
Patient Weight67
-
-